Assist Prof Dr. Chen Huang | Bioinformatics | Best Researcher Award

Assist Prof Dr. Chen Huang, Macau University of Science and Technology, Macau

Academic Qualification

Assist. Prof. Dr. Chen Huang holds a Ph.D. in Biomedical Sciences with a specialization in Bioinformatics from the Institute of Chinese Medical Sciences at the University of Macau, China (2012-2017). He also earned an M.E. in Bioinformatics from the Biological Information Science and Technology Institute at Harbin Medical University, China (2007-2010). Dr. Huang began his academic journey with a B.S. in Biotechnology, focusing on Biopharmaceuticals, from the College of Life Science at Nanchang University, China (2003-2007). His diverse educational background has laid a strong foundation for his pioneering research in bioinformatics.

Working Experiances

Assist. Prof. Dr. Chen Huang is currently serving as an Assistant Professor at the State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macao, a position he has held since 2020. Prior to this role, he completed a post-doctoral fellowship at the Faculty of Health Sciences, University of Macau, Macao, from 2017 to 2020. Before his post-doctoral tenure, Dr. Huang worked as an Analyst at the Beijing Genomics Institute in Shenzhen (BGI-Shenzhen) from 2010 to 2012.

Publication Top Notes

Lu, C., Huang, C., Qu, S., Lin, H., Zhong, H.-J., & Chong, C.-M. (2024). Oxyimperatorin attenuates LPS-induced microglial activation in vitro and in vivo via suppressing NF-κB p65 signaling. Biomedicine & Pharmacotherapy. https://doi.org/10.1016/j.biopha.2024.116379

Yang, X., Wu, Y., Chen, X., Qiu, J., & Huang, C. (2024). The transcriptional landscape of immune-response 3′-UTR alternative polyadenylation in melanoma. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25053041

Zhang, Y.-Z., Lai, H.-L., Huang, C., Jiang, Z.-B., Yan, H.-X., Wang, X.-R., Xie, C., Huang, J.-M., Ren, W.-K., Li, J.-X., Zhai, Z.-R., Yao, X.-J., Wu, Q.-B., & Leung, E. L.-H. (2024). Tanshinone IIA induces ER stress and JNK activation to inhibit tumor growth and enhance anti-PD-1 immunotherapy in non-small cell lung cancer. Phytomedicine. https://doi.org/10.1016/j.phymed.2024.155431

Cheng, X., Deng, M., Wang, Z., & Huang, C. (2024). MMP3C: An in-silico framework to depict cancer metabolic plasticity using gene expression profiles. Briefings in Bioinformatics. https://doi.org/10.1093/bib/bbad471

Wang, Z., Chen, X., Si, W., & Huang, C. (2023). Systemic pharmacology and bioinformatics: Exploring the modern biological mechanisms of rhubarb in the treatment of papillary thyroid carcinoma. MedComm – Future Medicine. https://doi.org/10.1002/mef2.69

Huang, C., Deng, M., Leng, D., Sun, B., Zheng, P., & Zhang, X. D. (2023). MIRS: An AI scoring system for predicting the prognosis and therapy of breast cancer. iScience. https://doi.org/10.1016/j.isci.2023.108322

Feng, Y., Chen, X., Zhang, X. D., & Huang, C. (2023). Metabolic pathway pairwise-based signature as a potential non-invasive diagnostic marker in Alzheimer’s disease patients. Genes. https://doi.org/10.3390/genes14061285

Cheng, T., Wu, Y., Liu, Z., Yu, Y., Sun, S., Guo, M., Sun, B., & Huang, C. (2022). CDKN2A-mediated molecular subtypes characterize the hallmarks of tumor microenvironment and guide precision medicine in triple-negative breast cancer. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2022.970950

Wu, L., Hou, X., Luo, W., Hu, H., Zheng, X., Chen, Y., Cheng, Z., Huang, C., & Sun, B. (2022). Three patterns of sensitization to mugwort, timothy, birch, and their major allergen components revealed by latent class analysis. Molecular Immunology. https://doi.org/10.1016/j.molimm.2022.03.009

Cheng, T., Chen, P., Chen, J., Deng, Y., & Huang, C. (2022). Landscape analysis of matrix metalloproteinases unveils key prognostic markers for patients with breast cancer. Frontiers in Genetics. https://doi.org/10.3389/fgene.2021.809600